-
LONG-TERM OUTCOMES OF FIBROMYALGIA PATIENTS WITH AND WITHOUT INSOMNIA: A REAL-WORLD COHORT STUDY
Feb 25, 2026, 14:41 PM -
EXPLORING THE OPTIMAL SHARE OF PHARMACEUTICAL VALUE FOR INDUSTRY AND SOCIETY: AN APPLICATION TO THE US CONTEXT
Feb 25, 2026, 14:41 PM -
PERIOPERATIVE COST-EFFECTIVENESS OF PARTIAL NEPHRECTOMY TECHNIQUES FOR RENAL CELL CARCINOMA IN THE UNITED STATES
Feb 25, 2026, 14:41 PM -
FORMULARY EXCLUSIONS AND NON-ADHERENCE TO DISEASE-MODIFYING THERAPIES FOR MULTIPLE SCLEROSIS IN MEDICARE PART D
Feb 25, 2026, 14:41 PM -
THE IMPACT OF THE FIRST FAMILY CORONAVIRUS RESPONSE ACT ON HEALTHCARE SERVICE UTILIZATION AMONG MEDICAID BENEFICIARIES WITH SICKLE CELL DISEASE IN WISCONSIN
Feb 25, 2026, 14:41 PM -
MODELING THE LIFETIME BENEFITS OF ETEPLIRSEN IN PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY
Feb 25, 2026, 14:41 PM -
ASSESSING THE CONCORDANCE BETWEEN SELF-REPORTED NICOTINE PRODUCT USE AND EMR DIAGNOSIS CODES IN THE ALL OF US RESEARCH PROGRAM
Feb 25, 2026, 14:41 PM -
COST-UTILITY ANALYSIS OF SACITUZUMAB TIRUMOTECAN (SAC-TMT) IN PREVIOUSLY TREATED EGFR-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS: A CHINESE HEALTHCARE SYSTEM PERSPECTIVE
Feb 25, 2026, 14:41 PM -
REAL-WORLD SURVIVAL AND PREDICTORS OF MORTALITY IN HEMATOLOGIC MALIGNANCIES DURING AN ERA OF THERAPEUTIC ADVANCEMENT AND HEALTHCARE DISRUPTION: A POPULATION-BASED SEER STUDY
Feb 25, 2026, 14:41 PM -
TITLE: COST-UTILITY ANALYSIS OF CALCITONIN GENE-RELATED PEPTIDE ANTIBODIES FOR PATIENTS WITH CHRONIC MIGRAINE: A UNITED STATES PAYER PERSPECTIVE
Feb 25, 2026, 14:41 PM -
CLINICAL AND ECONOMIC IMPACT ASSESSMENT OF HORMONAL IUD USE IN REDUCING UNPLANNED PREGNANCIES IN BRAZIL: REAL-WORLD ANALYSIS FROM A BRAZILIAN HEALTH INSURANCE COMPANY
Feb 25, 2026, 14:41 PM -
CONCEPTUAL COST-EFFECTIVENESS FRAMEWORK FOR GMRX2 (TELMISARTAN/AMLODIPINE/INDAPAMIDE) AS EARLY COMBINATION THERAPY FOR US ADULTS WITH HYPERTENSION WITHOUT MAJOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE, USED EITHER AT INITIATION OR AS A STEP-UP FROM...
Feb 25, 2026, 14:41 PM -
ASSOCIATION BETWEEN PINEAL NEOPLASM AND ALZHEIMER’S DISEASE PROGRESSION IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT: A POPULATION-BASED COHORT STUDY
Feb 25, 2026, 14:41 PM -
PATTERNS AND PREDICTORS OF ANTIDEPRESSANT USE AMONG ADULTS WITH DEPRESSION IN THE UNITED STATES
Feb 25, 2026, 14:41 PM -
EXPLORING THE ASSOCIATION BETWEEN CAREGIVER QOL AND THE CARE PROVIDED TO ADULTS WITH SEVERE VISUAL IMPAIRMENT CAUSED BY RARE DISEASE
Feb 25, 2026, 14:41 PM -
SOCIODEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF LATANOPROSTENE BUNOD INITIATORS AMONG MEDICARE FEE-FOR-SERVICE PATIENTS WITH OPEN ANGLE GLAUCOMA AND OCULAR HYPERTENSION
Feb 25, 2026, 14:41 PM -
DRIVERS OF MOBILE PATIENT PORTAL APP USE: INSIGHTS FOR IMPLEMENTATION AND VALUE-BASED DECISION-MAKING
Feb 25, 2026, 14:41 PM -
THE IMPACT OF GENERALIZED RISK ADJUSTED COST-EFFECTIVENESS ANALYSIS (GRACE) ON VALUE ASSESSMENT: FROM FORMAL ADOPTION TO GLOBAL METHODOLOGICAL TRENDS
Feb 25, 2026, 14:41 PM -
COMPARATIVE PHARMACOECONOMIC ASSESSMENT OF CDK4/6 INHIBITORS IN A LARGE BRAZILIAN PRIVATE PAYER
Feb 25, 2026, 14:41 PM -
RISKY BUSINESS: HOW HEALTH PREFERENCE RESEARCH CAPTURES RISK TOLERANCE
Feb 25, 2026, 14:41 PM
